RetinalGenix Technologies Inc. (RTGN) Financial Statements (2026 and earlier)

Company Profile

Business Address 1450 NORTH MCDOWELL BOULEVARD
PETALUMA, CA 94954
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments14,7746,060 384,947
Cash and cash equivalent14,7746,060 384,947
Total current assets:14,7746,060 384,947
Noncurrent Assets
Operating lease, right-of-use asset4,2726,835   
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization (307)56156256 
Deferred costs     70,974
Other undisclosed noncurrent assets2,3021,995  (70,974)
Total noncurrent assets:6,2678,886156256 
TOTAL ASSETS:21,04114,9461562944,947
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,084,763922,083884,920475,480253,901
Interest and dividends payable✕✕✕✕✕2,619
Accounts payable     251,282
Accrued liabilities19,27915,43911,5997,759 
Other undisclosed accounts payable and accrued liabilities1,065,484906,644873,321467,721 
Debt49,00049,00049,00049,00073,000
Due to related parties✕✕✕✕537,118142,721
Other undisclosed current liabilities1,186,205499,929   
Total current liabilities:2,319,9681,471,012933,9201,061,598469,622
Noncurrent Liabilities
Liabilities, other than long-term debt3,6846,544   
Operating lease, liability3,6846,544   
Total noncurrent liabilities:3,6846,544   
Other undisclosed liabilities   471,8937,759 
Total liabilities:2,323,6521,477,5561,405,8131,069,357469,622
Equity
Equity, attributable to parent(2,302,611)(1,462,610)(1,405,657)(1,069,063)(464,675)
Common stock1,8751,8521,8191,7831,423
Additional paid in capital15,679,13114,115,5609,701,7197,947,4604,638,218
Accumulated deficit(17,858,617)(15,430,022)(11,109,195)(9,018,306)(5,104,316)
Stockholders' equity note, subscriptions receivable (125,000)(150,000)   
Total equity:(2,302,611)(1,462,610)(1,405,657)(1,069,063)(464,675)
TOTAL LIABILITIES AND EQUITY:21,04114,9461562944,947

Income Statement (P&L) (USD)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating expenses(2,424,590)(4,316,987)(2,087,049)(3,908,850)(2,176,675)
Operating loss:(2,424,590)(4,316,987)(2,087,049)(4,361,897)(2,980,672)
Interest and debt expense(4,005)(3,840)(3,840)(5,140)(2,619)
Loss from continuing operations:(2,428,595)(4,320,827)(2,090,889)(4,367,037)(2,983,291)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(2,983,291)
Net loss:(2,428,595)(4,320,827)(2,090,889)(4,367,037)(2,983,291)
Other undisclosed net income attributable to parent    453,047803,997
Net loss available to common stockholders, diluted:(2,428,595)(4,320,827)(2,090,889)(3,913,990)(2,179,294)

Comprehensive Income (USD)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Net loss:(2,428,595)(4,320,827)(2,090,889)(4,367,037)(2,983,291)
Comprehensive loss, net of tax, attributable to parent:(2,428,595)(4,320,827)(2,090,889)(4,367,037)(2,983,291)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: